The Canterbury District Health board is delighted the Ministers of Health and
Economic Development have approved the establishment and funding of the New
Zealand Health Innovation hub.
The Hub will involve a small team of clinical leaders and commercialisation
experts, based in Canterbury and the three metro Auckland District Health
Boards. Dr Helen Lunt has been appointed as Canterbury’s Clinical Director
Innovation to lead the southern arm.
The Hub’s projected cost is around $24 million over five years, with the
Government committing $3 million to the project and the balance made up of
public and private sectors.
David Meates, Canterbury District Health Board chief executive, says the
Health Innovation Hub is about connecting the health system with industry in
development, validation and commercialisation of health technology products and
“The Canterbury Health System is thrilled to be a part of this exciting
initiative,” Mr Meates says.
“They will provide services to help develop ideas generated by clinicians or
industry into business propositions, products or services.”
The foundation stakeholders are Counties Manukau, Waitemata, Auckland and
Canterbury District Health Boards.
It will also have association relationships with universities, Crown Research
Institutes and industry groups.
The Hub will have a central executive and independent governance board, an
advisory panel of internationally recognised experts to advise on the commercial
and clinical viability of each business case.
The Hub will provide three types of services:
Testing and reference site services: It will assist international and
established domestic companies to collaborate with clinicians to develop and
test new products and services. This will include large scale clinical trials
and also reference site testing, demonstrating the effectiveness of new products
and services in a DHB setting.
Commercialisation of Intellectual Property: Staff will work with business,
researchers and clinicians to identify and screen projects, help refine the
concepts and facilitate access to market research because of diligence,
commercialisation and investment expertise.
Distribution of Service Improvement Intellectual Property: Innovation in
models of care and health services forms valuable IP, which is currently trapped
in various pockets of the New Zealand health system. Hub staff will assist in
identifying projects and help package ideas for distribution amongst the
National Health Board and Health Quality and Safety Commission across the New
Zealand health system and potentially for international sale.
Media Releases Archive